Possible serotonin syndrome associated with buspirone added to fluoxetine

Annals of Pharmacotherapy

Volumn 34, Issue 7-8, 2000, Pages 871-874

  Manos, Gail H ^a  

^a NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

Author keywords

Buspirone; Fluoxetine; Serotonin syndrome

Indexed keywords

BUSPIRONE; FLUOXETINE; SEROTONIN 1A RECEPTOR;

ADULT; ANXIETY NEUROSIS; ARTICLE; CASE REPORT; CONFUSION; COORDINATION; DIAPHORESIS; DIARRHEA; HUMAN; MALE; MYOCLONUS; PRIORITY JOURNAL; SEROTONIN SYNDROME;

EID: 0033913579     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.19341     Document Type: Article

References (25)

1. Joffe RT, Schuller DR. An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression. J Clin Psychiatry 1993;54:269-71.
2. Sussman N. The uses of buspirone in psychiatry. J Clin Psychiatry 1994; 12(monograph 1):3-19.
3. Landen M, Eriksson E, Agren H, Fahlen T. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1999;19:268-71.
4. Grady TA, Pigott TA, L'Heureux F, Murphy DL. Seizure associated with fluoxetine and adjuvant buspirone therapy (letter). J Clin Psychopharmacol 1992;12:70-1.
5. Metz A. Interaction between fluoxetine and buspirone (letter). Can J Psychiatry 1990;35:722-3.
6. Lebert F, Pasquier F, Goudemand M, Petit H. Euphoria with buspirone after fluoxetine treatment (letter). Am J Psychiatry 1993;150:167.
7. Tanquary J, Masand P. Paradoxical reaction to buspirone augmentation of fluoxetine (letter). J Clin Psychopharmacol 1990;10:377.
8. Bodkin JA, Teicher MH. Fluoxetine may antagonize the anxiolytic action of buspirone (letter). J Clin Psychopharmacol 1989;9:150.
9. Feighner JP, Boyer WF, Tyler DL, Neborsky RJ. Adverse consequences of fluoxetine-MAOI combination therapy. J Clin Psychiatry 1990;51: 222-5.
10. Muly EC, McDonald W, Steffens D, Book S. Serotonin syndrome produced by a combination of fluoxetine and lithium (letter). Am J Psychiatry 1993;150:1565.
11. Steomer W, Fontaine R. Toxic reaction following the combined administration of fluoxetine and L-tryptophan: five case reports. Biol Psychiatry 1986;21:1067-71.
12. Lane R, Baldwin D. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol 1997;17:208-21.
13. Baetz M, Malcolm D. Serotonin syndrome from fluvoxamine and buspirone (letter). Can J Psychiatry 1995;40:428-9.
14. Spigset O, Adielsson G. Combined serotonin syndrome and hyponatraemia caused by a citalopram-buspirone interaction. Int Clin Psychopharmacol 1997;12:61-3.
15. Goldberg RJ, Huk M. Serotonin syndrome from trazodone and buspirone (letter). Psychosomatics 1992;33:235-6.
16. Nijhawan PK, Katz G, Winter S. Psychiatric illness and the serotonin syndrome: an emerging adverse drug effect leading to intensive care unit admission. Crit Care Med 1996;24:1086-9.
17. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991;148:705-13.
18. Gillman PK. The serotonin syndrome and its treatment. J Psychopharmacol 1999;13:100-9.
19. Eison S, Temple D. Buspirone: a review of its pharmacology and current perspectives on its mechanism of action. Am J Med 1986;80(suppl 3b):S1-9.
20. Mahmood I, Sahajwalla C. Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug. Clin Pharmacokinet 1999;36: 277-87.
21. Preskorn S. Clinically relevant pharmacology of selective serotonin reuptake inhibitors: an overview with emphasis on pharmacokinetics and effects an oxidative drug metabolism. Clin Pharmacokinet 1997;32(suppl 1):S1-21.
22. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiologic messenger. Ann Intern Med 1994;120:227-37.
23. Ito A, Egashira K, Kadokami T, Fukumoto Y, Takayanagi T, Nakaike R, et al. Chronic inhibition of endothelium-derived nitric oxide synthesis causes coronary microvascular structural changes and hyperreactivity to serotonin in pigs. Circulation 1995;92:2636-44.
24. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
25. Eison AS, Eison MS, Stanley M, Riblet LA. Serotonergic mechanisms in the behavioral effects of buspirone and gepirone. Pharmacol Biochem Behav 1986;24:701-7.